CHICAGO & NEW YORK--(BUSINESS WIRE)--CG Life, a science-first, tech-enabled agency for life science, has acquired Berry & Company Public Relations, a New York City-based public relations agency focused on service to life sciences and medical technology companies. The acquisition significantly expands the range of CG Life communications expertise and services to support clients in the biopharma and medical sectors.
Berry & Company is a specialized PR firm with more than 25 years of experience in healthcare communications. The agency provides a complete range of public relations services to clients, including traditional and sponsored media, social media strategy and execution, content development, issues management, and crisis communications with expertise across a range of therapeutic areas, including rare diseases, oncology, immunology, neurological diseases, and orthopedic surgery.
“More than ever, today's marketing and communication agencies must be closely aligned with both their clients and the rapidly growing epicenters of innovation in healthcare. With Berry & Company’s pharma capabilities and New York presence, we are strategically positioned at the heart of the action in one of the world’s most robust and dynamic environments for life science innovation,” said CG Life CEO David Ormesher. “This marks CG Life’s second acquisition in one month, further emphasizing our commitment to building a new and powerful force in life sciences communications."
The acquisition of Berry & Company represents another milestone in CG Life's growth strategy. In April 2024, the company announced its acquisition of Toolhouse, a leading digital marketing agency for biopharma.
“We are continuing to execute our vision to build the premier science-first, technology-enabled omnichannel healthcare communications agency. The combined expertise of CG Life, Toolhouse, and Berry & Company positions us to deliver a more comprehensive range of services and deep expertise to deliver positive results for leaders in pharma, life science, and healthcare technology,” added Ormesher.
Following the acquisition, Berry & Company’s leadership team has joined CG Life. Bill Berry will serve as Senior Vice President, Public Relations, Adam Daley as Vice President, Social Media, and Tim McDonough as Vice President, Finance.
“We are very pleased to have the opportunity to combine our experience with the wide range of capabilities available at CG Life. We share their vision of outstanding service to clients to drive innovation and meaningful outcomes,” said Berry & Company Principal and Founder Bill Berry. “We look forward to unlocking new opportunities together and delivering even greater value to our clients through a combined critical understanding of life science and broader integrated healthcare communications.”
About Berry & Company Public Relations
For more than 25 years, Berry & Company has developed and executed public relations programs that support well-informed healthcare decisions. Our clients have included both emerging and established pioneers in healthcare technology and drug development, and our customized programs have played a central role in supporting hundreds of landmark advances in medical science including more than 60 FDA approvals and 300+ preclinical and clinical research programs. We have also been privileged to work in close collaboration with hundreds of leaders in clinical care, pharmaceutical, biotechnology, and medical device research and patient advocacy. Visit berrypr.com to learn more.
About CG Life
For more than two decades, CG Life has provided integrated marketing solutions to companies leading the way in therapeutics, medical devices, diagnostics, and research tools and services. Committed to the profound impact of science on everyday lives, CG Life blends scientific understanding, strategic imagination, and digital innovation to guide clients through the biggest leaps they make. Visit cglife.com to learn more.
